Purpose
|
Pramipexole is a medication indicated for treating Parkinson's disease and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache or to counteract the problems with low libido experienced by some users of SSRI antidepressant drugs. Pramipexole has shown robust effects on pilot studies in bipolar disorder. Pramipexole is classified as a non-ergoline dopamine agonist.
|
Characteristics
|
Tradename: Mirapexin, Sifrol Target: 5-HT receptor antagonist,Adrenergic Receptor antagonist ,Dopamine Receptor Receptor: 5-HT receptor ,α-adrenergic receptor,Dopamine receptor
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99.00?%
|
Formula
|
C10H17N3S
|
Solubility
|
DMSO 42 mg/mL,Ethanol 42 mg/mL,Water <1 mg="" ml="" <="" td="">
1> |